Eurovet Animal Health has launched Thyforon Flavoured (levothyroxine sodium, POM-V), which replaces the company's canine hypothyroid treatment Forthyron.
Eurovet says that Thyforon Flavoured has the same clinical efficacy of Forthyron and veterinary surgeons won't need to make any dose adjustments when transitioning to the new product.
However, Thyforon Flavoured, with its palatable formulation, now offers the benefit of being voluntarily accepted by over 70 per cent of dogs in taste trials1. In addition there is a new 800 mcg formulation which gives more prescribing options, particularly for the treatment of large and giant breeds.Thyforon Flavoured comes as easy-break tablets to make dose adjustment straightforward, in an easy-to-dispense blister pack.
Thyforon Flavoured is available now - the person responsible for placing the practice drug order should just ask for Thyforon Flavoured when placing the next drug order and where appropriate, the practice management system should be updated to reflect the new name.
Reference1. Eurovet Animal Health Internal Study report, acceptance study, November 2011
Animalcare has launched Emdocam (meloxicam 20mg/ml), a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class for use in cattle, pigs and horses.
According to the company, Emdocam disrupts the inflammatory cascade by inhibiting prostaglandin synthesis. It is a potent and preferential inhibitor of COX-2, permitting sufficient COX-1 sparing activity. It has analgesic and anti-inflammatory effects. When administered in a single dose to cattle, it has long acting anti-endotoxic, anti-pyretic and anti-inflammatory effects for up to three days.1,2
In cattle, it is indicated for bovine respiratory disease (BRD), clinical mastitis and calf scour. Animalcare says early use of meloxicam for BRD reduces pyrexia and pain, especially in young calves and improves feed intake. Meloxicam plus an antibiotic significantly reduced the extent of lung lesions, leading to improved clinical efficacy and daily liveweight gain in comparison with animals treated with antibiotics alone, for example oxytetracycline,3 florfenicol4and tilmicosin. 5
In the case of clinical mastitis, Animalcare says that used adjunctively with an antibiotic, Emdocam helps relieve local and systemic inflammation, returns the udder to a normal condition and reduces the polymorphonuclear leucocytes (PMN) response. In a large scale, double-blinded study in New Zealand, the addition of meloxicam to antibiotic therapy resulted in lower Somatic Cell Counts and a reduced risk of culling in dairy cows with mild clinical mastitis.6
Calf scour treated with meloxicam, as a supportive therapy, can improve calf well-being and reduce morbidity. In a double-blinded, controlled study, the use of meloxicam improved daily water and feed intake, added greater average bodyweight (bw) gain and helped calves to wean earlier. 7
In horses, administered IV at 3.0ml/100kg bw, Emdocam can be used for musculo-skeletal disorders, as well as colic, resulting in reduced pain and inflammation. In a study of 18 horses comparing flunixin with meloxicam and designed to determine the effect on recovery of ischemic-injured jejunum, meloxicam was found to be a useful alternative for the post-operative treatment of colic. 8
Emdocam is also indicated in pigs for non-infectious locomotive disorders and as an adjunctive therapy with an antibiotic in puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome).
Tony Liepman from Animalcare said: "Emdocam is competitively priced whether used on its own or adjunctively with a long-acting intramuscular (IM) antibiotic, such as Florgane suspension for the treatment of BRD in calves. This, coupled with its long lasting, low volume (2.5ml/100kg bw in cattle), single dose administration, by intravenous (IV) or subcutaneous (SC) injection, makes Emdocam a highly efficacious and practical NSAID."
Emdocam is a POM-V medicine and available as 50 and 100ml multi-dose vials. Withdrawal period in cattle for meat and offal is 15 days and in pigs for meat and offal is 5 days. In horses for meat and offal it is 5 days. In Florgane [POM-V], the withdrawal period for meat and offal is 37 days in cattle and not to be used in cattle producing milk for human consumption
References
Cattle
Research carried out by the Kennel Club to coincide with Mother's Day has revealed that 35% of dog buyers do not see their new puppy with its mother.
The research also found that one in ten buyers take their puppy home before it is eight weeks old, and that 55% do not see the puppy in its breeding environment.
Bill Lambert, Manager of the Kennel Club Assured Breeder Scheme, said: "March is the most popular month for searching for a puppy, but we are extremely concerned that so many are not seeing their puppy with its mother. Seeing mum not only helps people to find out how their puppy will be likely to turn out in terms of temperament and characteristics, but it also gives them the reassurance that it has been bred in a loving environment where it has been cared for and socialised properly."
Marc Abraham, TV vet and Kennel Club Veterinary Advisor, said: "Puppies depend on their mums in the early weeks of life, not just for milk but she's also critical for developing their socialisation skills which help set them up for life. If a breeder refuses to show the puppy with its mother without very good reason, then buyers should go elsewhere."
The Kennel Club is urging people to see puppies with their mother as part of its Stop Puppy Farming campaign and is joining with Marc Abraham to support the 'Where's Mum?' campaign. Kennel Club research has shown that as many as one in four could unwittingly be buying their puppy from a puppy farm.
The Kennel Club will be running a National Puppy Awareness Week (PAW) from the 8th - 14th September. To find out more visit www.thekennelclub.org.uk/stoppuppyfarming.
Ceva Animal Health, manufacturer of Feliway and Adaptil, is making a last call for nominations for its awards for animal welfare, which must be received by 27th January 2012.
The inaugural awards, which take place during WSAVA/BSAVA/FECAVA Congress in Birmingham in April, formally recognise veterinary professionals and individuals who have gone the extra mile to improve animal welfare both in practice and beyond. The awards feature three categories:
Prizes include a trip to New Zealand WSAVA in 2013 for the winner of the Chris Laurence Vet of the Year Award, a trip to a European Animal Welfare Congress for the winner of the Welfare Nurse of the Year Award and £1,000 worth of travel vouchers for the winner of the Pet Lover's Welfare Award.
Nomination forms can be downloaded from www.ceva.co.uk. Nominations should consist of full details about why the nominee deserves to win. Judging will be based on support materials such as case studies, examples and pictures, demonstrating the nominee's commitment to animal welfare. Anyone, whether a veterinary professional, pet owner or animal lover can nominate. All those who have nominated someone for an award will be entered into a prize draw to win £250 of high street vouchers.
For further information, telephone Ceva Animal Health on 01494 781510, email welfare.awards@ceva.com or contact your local Ceva territory manager.
Henry Schein, Inc. has announced the acquisition of Veterinary Instrumentation, the supplier of surgical instruments and implants to veterinary surgeons in the United Kingdom.
Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein said: "We are delighted to welcome this highly regarded company to the Henry Schein family, and very pleased that founder John Lapish and Managing Director Steve Fletcher will continue to drive the business forward.
"The success of Veterinary Instrumentation closely parallels the cornerstones of Henry Schein, including a deep understanding of customer needs, innovative solutions, superior product quality and customer service, and a trusted advisory relationship with our customers. Reinforcing our existing animal health business in the U.K., we look forward to strengthening our relationship with veterinary customers in this region, and bringing the Veterinary Instrumentation product portfolio of high-quality surgical specialties to a growing number of veterinarians across Europe, the United States and Australasia."
Veterinary Instrumentation was founded by John Lapish in 1986 in Sheffield, England, where the business and distribution operations are currently conducted from a single facility. Working as a small animal orthopaedic surgeon in the late 1970s, Mr. Lapish began designing and developing a range of instruments specifically for veterinary surgery, initially for his own use. As requests for these products increased, the market need became clear and Veterinary Instrumentation was formed, in particular to meet the needs of orthopaedic surgeons focused on small animals.
Mr Lapish said: "We look forward to contributing to the continued growth and success of a leading supplier of companion animal health products and services in the United Kingdom and to becoming part of a global leader in the distribution of health care products and services.
"The expertise that we bring in the area of veterinary surgical instruments will complement Henry Schein's broad offering, and our customers will benefit greatly from the global resources of a company that has quickly become an animal health care product and service leader on three continents."
With approximately 60 percent of sales in the U.K., and the balance split fairly evenly between Europe and the rest of the world, Veterinary Instrumentation has 20 employees, including a team of eight Veterinary Technicians who advise customers on the most appropriate procedures and instrumentation.
Veterinary Instrumentation sales for the 12 months ended September 30, 2011 were approximately £6.7 million ($10.8 million). Financial terms of the transaction were not disclosed.
Elanco has launched a new poultry tonic designed to support birds during the most demanding periods of productivity: during growth and peak laying.
The launch follows Elanco's acquisition of Janssen Animal Health and its existing poultry poultry tonic, which Elanco has improved.
Elanco Poultry Tonic HD Plus contains two new ingredients: a vitamin D3 metabolite and a natural antioxidant blend.
Elanco says the new product could prove just the tonic for the poultry industry in the face of rising fuel and feed costs. One study has apparently demonstrated as much as a 5:1 return on investment can be made as a result of supplementing the D3 metabolite alone.1According to the company, the vitamin D3 metabolite has been shown to increase egg weights (by around 2 per cent) and improve feed conversion and feed intake. It is more available to the body than vitamin D3, which plays a role in calcium metabolism (and therefore egg production). The benefits are significant for commercial egg producers but also for hatcheries, as egg size correlates with chick weight. Elanco says the metabolite can also improve bone strength, potentially resulting in healthier, more robust poults.The new antioxidant blend contains natural preparations of vitamins as well as more complex antioxidants found in fruits and vegetables, such as flavanoids, polyphenols and carotenoids. It also contains nucleotides and sulphur containing amino acids, methionine and lysine. Elanco's new Poultry Tonic HD Plus is suitable for layers, broilers, breeders and turkeys and is available from veterinary wholesalers and animal health distributors. The company is also launching Game Bird Tonic HD Plus at the same time.
Reference
1. SOTO-SALANOVA MF MOLINERO A, Efficacy of the use of Hy-D® in laying hens, XI th European Symposium on the Quality of Eggs and Egg Products 191 Doorwerth, The Netherlands, 23-26 May 2005
Gordon Hockey has been appointed Acting Registrar at the Royal College of Veterinary Surgeons.
He succeeds Jane Hern, who had been Registrar for 15 years before deciding to move on to pursue other interests.
Gordon, who is a qualified pharmacist and barrister, has been at the College for the last 13 years as Head of the Professional Conduct Department and Assistant Registrar.
Meanwhile, the College says it is giving consideration to the future scope of the Registrar and Secretary's roles, as the Officer team begins the recruitment process.
Eleanor Ferguson has taken over as Acting Head of the Professional Conduct Department.
The EAEVE (European Association of Establishments for Veterinary Education) has granted full accreditation to the Royal Veterinary College.
The RVC is the only one in the world to have achieved full accreditation by EAEVE and the American Veterinary Medical Association (AVMA), and full recognition by the UK's Royal College of Veterinary Surgeons.
Accreditation by EAEVE provides Europe-wide assurance of academic standards. Three other European veterinary schools have achieved accredited status: Copenhagen, Helsinki and Zurich/Bern.
Ticks infected with the bacteria that cause Lyme disease may be considerably more prevalent in the UK than recent estimates indicate, according to new research from the University of Bristol that used pet dogs as 'sentinels' for human disease risk.
Transmitted by ticks, Lyme disease is a debilitating chronic infection which affects a number of animals including humans and dogs. It is caused by the bacterium Borrelia burgdorferi. Clinical signs in humans include a characteristic circular red rash that spreads from the site of the tick bite, followed by a flu-like condition. In dogs, the symptoms can be much more vague and difficult to diagnose. If untreated, the disease progresses to neurological problems and arthritis; chronic forms of the disease can last for many years.
While only occasionally affecting humans, reported cases in the UK are thought to have increased more than fourfold since the beginning of the century - from 0.38 per 100,000 in 2000 to 1.79 per 100,000 in 2009. In 2010 there were 953 reported cases in England and Wales but the level of under-reporting is likely to be considerable.
To obtain a clearer picture of the prevalence of infected ticks, Faith Smith of Bristol's School of Biological Sciences and colleagues recruited veterinary surgeons across England, Scotland and Wales to examine dogs selected at random as they visited veterinary practices. Since pet dogs largely share the same environment and visit the same outdoor areas as their owners, exposure to infected ticks in dogs is likely to provide an index for corresponding risks to humans.
Of 3,534 dogs inspected between March and October 2009, 14.9% had ticks. Of the samples that could be tested, 17 (2.3%) were positive for the Borrelia bacteria. The expected prevalence of infected ticks on dogs is 0.5 per cent, or 481 infected ticks per 100,000 dogs. This suggests that the prevalence of Borrelia in the UK tick population is considerably higher than previously thought.
Faith Smith said: "Lyme disease appears to be a rapidly growing problem in the UK with important health and economic impacts in terms of loss of working hours and potential decrease in tourism to tick hotspots.
"Without considerably better surveillance and routine diagnostic testing, Lyme disease is only likely to become more prevalent. In particular, future warmer winters might well extend the period over which ticks are active seasonally, while growing wild reservoir host populations, such as deer, will allow the tick population to expand."
The study is published today in the journal Comparative Immunology, Microbiology and Infectious Diseases. The research was funded by the Natural Environment Research Council (NERC) and Merial Animal Health Ltd.
A new veterinary charity is offering veterinary surgeons, nurses and others in the profession the chance to get fit and raise money for Hounds for Heroes, SPANA and the Pet Blood Bank later this year.
The Vet Charity Challenge (VCC) is looking for teams to take part in a one-day event, involving a series of physical tasks and puzzle-solving challenges along the way, so it requires a bit of brain as well as brawn. The course will feature walking / running, cycling and kayaking and anyone can take part at whatever fitness level.
As well as raising money for the charities, organisers say it will be a fun way to build up camaraderie among your colleagues outside of the work environment and also a local PR opportunity for your practice or business to enhance your community profile.
The event is expecting to raise in excess of £30,000 for charity, but organisers stress that it will need the support of and participation by the veterinary profession to ensure it is a success.
The challenge will take place on Saturday 15th September 2012 at the Royal Agricultural College, Cirencester and all details may be found on http://www.vetcharitychallenge.co.uk/. Alternatively, ring 01727 859259 for further information. The VCC says an early commitment to take part is essential and the fine detail of training can be worked out later. The VCC will provide training guidelines and help you and your team prepare itself.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets 2 and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
The British Veterinary Association has reiterated its call for heightened vigilance following confirmation by AHVLA that Schmallenberg virus (SBV) has been detected on four sheep farms in Norfolk, Suffolk and East Sussex.
At this early stage the virus is understood to be vector-borne (although other routes of transmission have not been ruled out) and the clinical signs seen along with meteorological modelling of risk suggests that the four farms were affected during summer/autumn 2011, with congenital defects now becoming visible at lambing time.
Animals imported from the affected areas in northern Europe are also considered to be potentially at risk and their destination in the UK has been identified.
Congenital deformities and nervous defects are seen in newborn lambs, goat kids and calves. Clinical signs in affected cattle include pyrexia (fever), milk drop, and diarrhoea similar to what is often termed 'winter dysentery'. Farmers should be looking out for clusters of these signs within herds and flocks and reporting them to their veterinary surgeon.
Vets who are aware of suspicious clinical signs on their client's farms should report them to AHVLA, SAC or the local DARD divisional veterinary office for further investigation.
AHVLA, SAC and DARD have stated that they are keen to investigate potential cases and there will be no extra charge for the SBV tests that are undertaken, but their approaches are slightly different.
In England, Wales and Northern Ireland AHVLA and AFBI are carrying out SBV-only testing (ie to rule the disease in or out) free of charge but are charging the standard subsidised investigation charge for any additional diagnostic work.
In Scotland any carcases submitted for post mortem examinations are examined at the standard fee and all necessary examinations required by the VIO to investigate the case are included in the fee. SAC is not charging an additional fee for SBV testing.
Carl Padgett, President of the BVA, said: "The confirmation of Schmallenberg virus in sheep flocks in England is a reminder to vets and farmers across the UK to step up vigilance amongst ruminants.
"The BVA would encourage vets to speak to their local AHVLA, SAC or DARD team to discuss any suspect cases and consider submitting specimens for further investigation. We understand that in confirmed cases clinical signs occur in clusters and vets should ensure they know what to look for in both adult and perinatal ruminants.
"While the cases in the south east of England suggest the virus is vector-borne other potential routes of transmission are still being considered. Although the risk of zoonosis is believed to be very low it has not been ruled out and a sensible precautionary approach should be taken by those handling infected animals and specimens."
MSD Animal Health has launched an improved on-farm calf-side scour pathogen testing kit for faster diagnosis of the main infectious organisms implicated in a disease outbreak.
According to the company, the new ScourCheck Rapid Programme promises a 10-minute diagnostic turnaround from faecal sample to result, enabling the veterinary practitioner to offer more timely disease management recommendations without having to wait for a laboratory report. The new kits deliver on-farm identification of rotavirus, coronavirus, cryptosporidium and E. coli K99.
Further details on the ScourCheck Rapid Programme are available from MSD Animal Health account managers.
Kruuse has launched a new extra large size Bovivet Hoof Bandage for use in the treatment of digital dermatitis (DD) in cattle.
According to the company, an estimated 70 per cent of dairy herds suffer with digital dermatitis and, if not treated, it can persist for months, causing pain and lameness to infected cows. Indeed, a paper1 presented at the BCVA 2011 Congress by Prof. N.B. Cook, Clinical Associate Professor at the School of Veterinary Medicine in Madison, USA, said that "lameness can systematically undermine the management of the dairy herd. No other disease has such fundamental and extensive effects on production, reproduction and risk of early herd removal."
The most effective way to fight DD has been found to be the management and treatment of individual animals. Traditional treatments have involved thoroughly washing the infected hoof, applying an antibiotic/drying agent, such as salicylic acid powder, and then applying a dressing that must remain in place usually for three days. However, it can be hard to correctly dose the salicyclic acid powder and there can be complications in ensuring that the dressing is correctly applied at the right pressure and that it stays in place. It can also be a risk to the user's health when mixing the powder.
Kruuse says this can be made easier by using the Bovivet complete Hoof Bandage along with Kruuse Hoof Gel 38%. Firstly, by using a gel, dosing is easy and more accurate, making it more economical per treatment; and, secondly, for the user, it reduces potential health risks from inhalation of the powder when mixing.
Stuart Wilson from Kruuse UK said: "Since the launch in the UK early last year, the hoof bandage has been very well received by cattle vets, but we were told by them that a larger version was needed in some cases. So Kruuse has produced the new extra large size 'red Jimmy Choos for moos'!"
Kruuse has produced the following instructional video to demonstrate the products' ease of use and versatility, and says that the estimated cost per hoof, assuming ten treatments from a bottle of the gel, is £2.71.
Protek Biochem Ltd., a company set up by champion horse-rider Debbie Topping, has won the rights to sell Envirocair Veterinary, a new range of disinfectants and sanitisers targeted at dogs, cats and other domestic pets, as well as horses and farm animals.
The product is claimed to kill 99.99% of all viral, bacterial and fungal infections, and lasts for 14 days.
Debbie said: "I did not consider myself a businesswoman, just a normal horse-rider and animal lover. However, I was so impressed when I tried Envirocair Veterinary that, when I was offered the opportunity to become the main UK distributor, I jumped at the chance."
According to the company, the product is being used by a number of the horses and trainers heading to the London Olympics in 2012. It is now being rolled out across the rest of the UK's animal care sector.
Debbie says that veterinary surgeons, farmers, dog kennels, animal rescue centres, breeders and others will all be able to benefit from the new product: "Envirocair Veterinary doesn't harm skin or irritate the respiratory tract, so you don't need to get dressed up in special clothing every time you use it.
"Used properly, it quite literally kills the threat of major animal diseases such as parvovirus in dogs, which can otherwise be fatal in less than 72 hours.
"It's not an exaggeration to say that Envirocair will protect the health and even save the lives of countless numbers of animals across the UK."
Debbie signed the distribution agreement with the manufacturer Biotech International Ltd last month, before officially launching Envirocair Veterinary this week.
For more information on Protek Biochem Ltd or Envirocair Veterinary, visit http://www.protekbiochem.com/.
Virbac Animal Health has launched a special scheme to encourage farmers to have milk samples analysed in line with the industry-wide campaign to promote the responsible use of antimicrobials.
Under the terms of the scheme, veterinary surgeons purchasing Virbac's Cephaguard DC therapy will receive vouchers to distribute to their farmer clients. These vouchers can be redeemed for milk bacteriology to determine the pathogens causing mastitis and so ensure treatment is more targeted and effective.
Brigitte Goasduf MRCVS, Ruminants Marketing Manager at Virbac, said: "Mastitis is a major concern for dairy farmers with reported numbers of cases ranging from 26-50 for every 100 cows.
"Experts agree that individual SCC monitoring and the accurate diagnosis of pathogens causing infection are key to treating mastitis effectively. Unfortunately many farmers are often deterred by the cost.
"Our scheme gives our veterinary customers the opportunity to foster good practice by encouraging farmer clients to submit milk samples for investigation at no cost to them. This will then enable them to treat the bacteria causing the infection in line with industry guidelines for the use of antimicrobials.
"Over time, we believe farmers will come to realise that adopting this more targeted approach is not only more cost-effective but will also preserve their ability to treat their herd, both now and in the future."
For further information on the scheme, contact your Virbac territory manager or call Virbac on 01359 243243.
Henry Schein Inc., parent company of Henry Schein Animal Health has been named as one of Ethisphere's 2012 World's Most Ethical Companies.
The Ethisphere Institute is an international think-tank dedicated to the creation, advancement and sharing of best practices in business ethics, corporate social responsibility, anti-corruption and sustainability. This is the sixth year that Ethisphere Institute has published the World's Most Ethical Companies list.
Out of more than 5,000 nominations for the World's Most Ethical Companies award this year, Henry Schein was named to the list of 145 companies for raising the bar for ethical standards within the health care industry through exemplary ethical leadership, worldwide business standards and commitment to corporate social responsibility.
Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc. said: A deep commitment to the highest ethical standards and business practices has been a hallmark of Henry Schein since our founding in 1932, and continues to be at the very core of our business model as we have grown to become a Fortune 500 company with operations around the globe and nearly 15,000 Team Schein Members."
Virbac Animal Health has launched an enhanced version of its flea and tick spot-on Effipro (fipronil) to help pet owners master the art of 'spotonologyTM - a Maureen-Lipmanesque term the company has coined to describe the optimum application of a spot on treatment.
Effipro is now presented in a clear pipette featuring 'Drop-lock' technology to provide precise finger tip control of the flow of liquid with no risk of drip or leakage. The pipette has also been redesigned to ensure it is simple to open and that users can easily check that all the treatment has been dispensed.
Virbac says Effipro is priced to offer an effective but affordable solution to parasite control. It is presented in client packs of four pipettes and in practice packs of 24 to offer flexible dispensing opportunities. It is also available in a spray form.
Victoria Hudson, Product Manager at Virbac, said: "Parasite control is a key revenue generator for many practices. It also presents a great opportunity to create loyal, bonded clients as fleas and ticks cause great concern to pet owners.
"Effipro is already a popular product but we know that some owners find using spot-ons difficult and worry about the risk of the liquid getting on to their fingers or on furniture, particularly if their pets move around while the treatment is being applied.
"With this in mind, we've taken a fresh look at the technology of spot-ons in order to ensure that we're providing a solution which is as simple and hassle-free as possible. As a first step, we've redesigned our pipette. Our unique Drop-lock technology means that owners can start or stop the flow of liquid with their finger tips, giving them full control over where and when the product is applied. The new see-through design and enhanced opening mechanism also make the new version of Effipro more convenient to use.
"We've had great feedback from practices which have trialled the product and believe it represents a significant step forward for users of spot-ons. We are, of course, providing a range of support materials and product promotions to support its launch and look forward to working with our customers to ensure that their clients become expert and enthusiastic 'Spot.on.ologists' during 2012.
For further information about Effipro contact your Territory Manager or call Virbac on 01359 243243.
BVA members who join the Webinar Vet before the end of this month will receive a USB headset and microphone worth £40
Webinar Vet founder Anthony Chadwick MRCVS said: "The idea is to help new members get equipped and ready to listen and ask questions during the regular Thursday evening member webinars."
"BVA members already benefit from half price gold membership to the Webinar Vet and many have already taken advantage and are enjoying the many benefits of online CPD."
Gold membership includes invitations to weekly members' live CPD events, full access to the library of over 150 hours of categorised pre-recorded webinars, and a monthly CD of one of the presentations to listen to in the car.
All BVA members who sign up before March 31st will also qualify for the free headset. For more information visit www.bva.co.uk/webinar.
The RCVS Disciplinary Committee has dismissed an application for restoration to the RCVS Register from Dr Janos Nemeth, who was struck off in 2009 for fraudulent registration.
This was Dr Nemeth's second unsuccessful restoration application, and the Committee said it would hear no further application unless the Committee Chairman, advised by the Legal Assessor, considered it to have a reasonable prospect of success.
At the original hearing on the 23rd February 2009, Dr Nemeth, who had practised in the Wokingham area of Berkshire, was found to have dishonestly entered his name in the RCVS Register. Although he held a veterinary science degree from the Szent István University in Budapest, he had included a forged document in his registration application. He lodged an appeal with the Privy Council the following month, but did not pursue it; the appeal was dismissed in September 2009 and his name was removed from the Register. Dr Nemeth was ordered to pay costs of £8,904.59, which remain outstanding.
In September 2010, he applied to the RCVS Disciplinary Committee for restoration of his name to the RCVS Register, denying that he had produced a fraudulent document. In refusing the application, the then-Committee told Dr Nemeth that it had no appellate jurisdiction and that the onus was on him to demonstrate that he was a fit and proper person, before his name could be restored. It advised him generally about a future application for restoration.
At this week's restoration hearing, Dr Nemeth told the Committee that he did accept the original findings of the Committee but, at the same time, told them again that he was not party to the forgery. He also said that he held a licence to practise from the Hungarian Veterinary Chamber, and had been employed since October 2011 as a veterinary surgeon in a small animal hospital in Budapest, where he carried out a wide range of work including surgery. He also said he had attended two CPD courses.
The Committee accepted this. However, it continued to be concerned about the absence of evidence. Dr Nemeth had not produced evidence of CPD undertaken or provided letters of support from employers or colleagues, to give comfort to the assertion that he should be permitted to practise in the UK. The Committee rejected Dr Nemeth's argument that his licence to practise in Hungary meant he did not need to do this.
Committee Chairman Professor Peter Lees said: "The Committee is disappointed by Dr Nemeth's continuing lack of insight and is satisfied that he has paid insufficient attention to the guidance given at the previous restoration hearing. The burden remains on him to satisfy this Committee that he is a fit and proper person, before his name can be restored to the Register."
The application was dismissed.
The RCVS Disciplinary Committee has accepted an application for restoration to the RCVS Register by James Main, who was struck off in 2011, following his administration of a prohibited substance to a racehorse and his subsequent attempts to conceal his actions.
At a Disciplinary Committee hearing held on 22 February 2011, Mr Main, a partner in the O'Gorman, Slater, Main & Partners veterinary practice in Newbury was found guilty of serious professional misconduct and his name was removed from the Register. The then-Committee established that, contrary to the British Horseracing Authority's (BHA) rules of racing, Mr Main had injected tranexamic acid into the racehorse 'Moonlit Path' on 19 February 2009, knowing that the horse was to race later that day. He was also found guilty of dishonestly concealing this injection in his practice records as a "pre-race check".
At yesterday's hearing, the Committee noted that the decision to remove Mr Main from the Register had sent a clear message to the profession of the importance of strict compliance with the BHA's Rules of Racing; it was the inevitable consequence of his breaches of those rules and his dishonesty in concealing the administration of the injection. In oral evidence, Mr Main said he accepted the findings and decision of the previous Committee, and he apologised.
The Committee also noted a number of changes since implemented at Mr Main's practice, including a pharmacy review to improve traceability of drugs; withdrawal of the use of tranexamic acid in the management of Exercise Induced Pulmonary Haemorrhage; and a cautious approach to drug withdrawal times. Mr Main's practice had also reviewed its processes to ensure its veterinary surgeons complied with all relevant rules, regulations and guidance, and that any requests by clients to breach these rules would be refused.
The Committee accepted evidence that Mr Main had worked in a management capacity in his practice since 26 March 2011, performing no clinical role, and had undertaken appropriate continuing professional development since being removed from the Register. It also noted the large volume of testimonials and public support presented at the hearing from both veterinary surgeons and clients in the horse world.
Furthermore, it noted that removal had been financially and emotionally detrimental to Mr Main, his family and practice and, if his name were not restored to the Register, there would be a continuing detrimental effect on his family finances and the practice.
Committee Chairman Professor Peter Lees said: "The Committee accepts that Mr Main has found the removal of his name from the Register a humbling and salutary experience and accepts his apologies. It is satisfied that he is very unlikely to breach the rules of racing in the future and does not consider that there is a risk to the future welfare of animals by restoring his name to the Register.
"The Committee does not consider that any further period of erasure would be of benefit either to the public or the veterinary profession."
The Committee directed that Mr Main's name be restored to the Register.
Endell Veterinary Group Equine Hospital in Wiltshire has stationed an equine veterinary surgeon on the Isle of Wight permanently to ensure that the island's numerous horses can receive rapid treatment when they need it.
Florus Oskam MRCVS is providing a routine and emergency mobile ambulatory service around the island 24 hours a day. Florus also has the back up of mainland ambulatory vets who also spend time on the Island. Appointments with specific vets to visit the island can also be arranged.
Florus said: "We have been providing a veterinary service on the Isle of Wight for the past 30 years and have a very loyal client base. For years they have been asking us for a permanent service on the island and we are delighted to be able to provide it at last."
Anita Niccolls, dressage rider and trainer on the Isle of Wight, added: "It's very reassuring to know that a vet of Florus's calibre is now resident on the Island and that we are able to have continuity of vet care should a horse need further treatment at the practice's equine hospital in Salisbury."
MSD Animal Health has launched FlockCheck 2012, its complimentary sheep diagnostic service that identifies whether enzootic abortion or toxoplasmosis is present in a client's flock.
FlockCheck 2012 requires vets to take blood samples from 6-8 aborting ewes. MSD says that at a time when many farmers are asking for veterinary diagnostic support to confirm or rule out potential Schmallenberg virus infection, it makes sense to investigate whether other diseases are present in the flock at the same time.
MSD Animal Health ruminant veterinary adviser Drew McGurren MRCVS said: "Based on the previous two years' FlockCheck data (2011 and 2010), on average over 86% of submitted samples tested positive for toxoplasmosis and more than 62% were positive for enzootic abortion. Around 43% of samples showed exposure to both diseases.
"With lamb prices still remaining buoyant it has never been more important to ensure farmers minimise lamb losses. The 2012 FlockCheck service allows vets to identify whether toxoplasmosis or enzootic abortion is the cause of any aborted lamb losses and provides a starting point for discussions around the value of vaccination programmes with Enzovax and Toxovax."
Vets are asked to submit unit blood samples with the new 2012 FlockCheck forms.
The RCVS has restored its full approval to the University of Bristol's School of Veterinary Science.
The full approval was granted by the RCVS Council in March, at the recommendation of the Education Policy and Specialisation Committee (EPSC), following the positive report of a visitation carried out in mid-December 2011 under the chairmanship of former RCVS President Stephen Ware.
The School had been under conditional approval since a visit in March 2007, and a subsequent revisit in October 2009 had identified that although progress had been made, work still needed to be completed to improve some of the facilities, particularly in small animal surgery and on the farm.
The RCVS Council commended the hard work and improvements displayed by the School, and was pleased to restore it to full approval status.
Professor Stuart Reid, EPSC Chairman said: "The University has demonstrated a welcome and continued commitment to the development of the School, and is to be congratulated on making significant financial investments in staffing and facilities, despite the current difficult economic climate.
"There is a positive and constructive atmosphere, which is a credit to the Head of School and all the staff who have clearly worked extremely hard to meet the challenges presented to them at a time of change within the university sector as a whole."
The School is next scheduled for a full visitation in 2014.
Ceva Animal Health UK has launched a range of support materials to help educate veterinary professionals and cat owners about feline stress and the benefits of using Feliway.
For veterinary surgeons and nurses, the company has produced a series of video presentations by the Specialist in Feline Medicine, Danielle Gunn-Moore, in which she discusses feline stress and its link to cystitis. The videos are now available to watch here on VetSurgeon.org.
Also for veterinary surgeons, the company has produced an A3 decision tree featuring the practical approach to cystitis, developed by Danielle Gunn-Moore. In addition, there's a waiting room poster which details what resources are needed to create a cat-friendly home. The resource checklist consists of advice on basic resources such as food, water bowls and litter trays and hints and tips on how to reinforce confidence, develop structural features, stimulate activity and provide appropriate resources for a multi-cat household.
For owners, Ceva has produced a post-operative cat care information sheet. It is a question and answer style document covering advice on caring for a post-operative cat when it returns home.
To help highlight the benefits of Feliway, Ceva is also running a prize draw to win one of three Kindles, with three runners-up winning a Feline Infectious Disease book.
For further information on the new Feliway support materials or the prize draw, please contact your local Ceva account manager or telephone 01494 781510.
Exotics referral practitioner, Mark Rowland MRCVS CertZooMed MRCVS has launched an iPhone app for GPs which puts all the information you need about the commonly presented exotic species at your fingertips.
Mark said: "Vets often have little training in exotic animal medicine, an area which is becoming increasingly important as more rabbits, guinea pigs, hamsters, tortoises, other reptiles and birds are presented in practice. Although data is available in books, it usually has to be sourced, which can be difficult if the practice does not have the relevant texts."
"For this reason, I've developed an iPhone app which provides species biological data, such as normal temperatures and gestation periods, a exotics formulary, a list of common conditions and a gallery of images and video footage of basic procedures."
Mark says he hopes it'll be an invaluable mobile resource for veterinary surgeons, students, nurses and technicians worldwide, and that he will be updating it regularly.
Veterinary Care of Exotic Pets is now available now from iTunes, priced at £7.99. Click here for more information: http://itunes.apple.com/gb/app/veterinary-care-exotic-pets/id511902278?mt=8